WELLS FARGO & COMPANY/MN
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in APLS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
8,592
-91.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Derivatives in APLS
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
0
PutValue
$0
PutShares
21,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in APLS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 8,592 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | — | 103,815 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | — | 2,463 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | — | 1,043,655 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | — | 4,624 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | — | 5,616 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | — | 139,368 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | — | 160,228 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | — | 145,035 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | — | 132,567 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | — | 155,707 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | — | 92,195 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | — | 105,618 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | — | 16,945 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | — | 21,700 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | — | 19,598 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 15,802 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | — | 41,419 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | — | 63,925 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | — | 50,589 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | — | 36,199 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | — | 10,037 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | — | 48,423 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | — | 26,464 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | — | 40,600 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | — | 30,772 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||